Knights of Columbus Asset Advisors LLC

Position in DNLI — Denali Therapeutics Inc.

CIK 1688666 NEW HAVEN, CT

Position in DNLI

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$1,738,440

+$656,924 QoQ

Shares Held

67,591

+20.0% QoQ

Ownership

0.042%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#100

of 290 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Knights of Columbus Asset Advisors LLC holds $27,324,036 across 16 Biotechnology names. DNLI ranks #7 (6.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	14,071	$3,444,158
2	MIRM	Mirum Pharmaceuticals, Inc.	23,831	$2,789,895
3	KYMR	Kymera Therapeutics, Inc.	18,313	$2,099,951
4	RYTM	Rhythm Pharmaceuticals, Inc.	18,043	$2,003,314
5	COGT	Cogent Biosciences, Inc.	50,156	$1,941,037
6	IDYA	IDEAYA Biosciences, Inc.	47,328	$1,763,914
7	DNLI	Denali Therapeutics Inc. This page	67,591	$1,738,440
8	EWTX	Edgewise Therapeutics, Inc.	38,641	$1,569,983

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,738,440	67,591	+20.0%	Shares	Sole	2026-07-31
2026-03-31	$1,081,516	56,329	+14.9%	Shares	Sole	2026-05-11
2025-12-31	$809,105	49,007	-2.4%	Shares	Sole	2026-02-09
2025-09-30	$728,758	50,190	+30.4%	Shares	Sole	2025-11-03
2025-06-30	$538,321	38,479	-4.5%	Shares	Sole	2025-07-22
2025-03-31	$547,538	40,275	+2.7%	Shares	Sole	2025-05-07
2024-12-31	$799,242	39,217	+0.3%	Shares	Sole	2025-02-11
2024-09-30	$1,139,536	39,119	-32.5%	Shares	Sole	2024-11-12
2024-06-30	$1,346,643	57,995	+47.0%	Shares	Sole	2024-07-30
2024-03-31	$809,329	39,441	-49.0%	Shares	Sole	2024-05-10
2023-12-31	$1,659,973	77,352	+102.9%	Shares	Sole	2024-01-31
2023-09-30	$786,580	38,128	+3.1%	Shares	Sole	2023-11-01
2023-06-30	$1,091,191	36,977	—	Shares	Sole	2023-08-01
No filing history on record for this holder in this stock.